BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35219055)

  • 1. Microglia as therapeutic targets for central nervous system remyelination.
    Mahmood A; Miron VE
    Curr Opin Pharmacol; 2022 Apr; 63():102188. PubMed ID: 35219055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytes in central nervous system remyelination.
    Forbes LH; Miron VE
    Glia; 2022 May; 70(5):797-807. PubMed ID: 34708884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-remyelination properties of microglia in the central nervous system.
    Lloyd AF; Miron VE
    Nat Rev Neurol; 2019 Aug; 15(8):447-458. PubMed ID: 31256193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages and CNS remyelination.
    Miron VE; Franklin RJ
    J Neurochem; 2014 Jul; 130(2):165-71. PubMed ID: 24601941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting PKC in microglia to promote remyelination and repair in the CNS.
    Kim PM; Kornberg MD
    Curr Opin Pharmacol; 2022 Feb; 62():103-108. PubMed ID: 34965482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKC modulator bryostatin-1 therapeutically targets CNS innate immunity to attenuate neuroinflammation and promote remyelination.
    Gharibani P; Abramson E; Shanmukha S; Smith MD; Godfrey WH; Lee JJ; Hu J; Baydyuk M; Dorion MF; Deng X; Guo Y; Hwang S; Huang JK; Calabresi PA; Kornberg MD; Kim PM
    bioRxiv; 2023 Aug; ():. PubMed ID: 37693473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial cells as therapeutic targets in progressive multiple sclerosis.
    Wilbanks B; Maher LJ; Rodriguez M
    Expert Rev Neurother; 2019 Jun; 19(6):481-494. PubMed ID: 31081705
    [No Abstract]   [Full Text] [Related]  

  • 9. Innate and adaptive immune mechanisms regulating central nervous system remyelination.
    Creswell R; Dombrowski Y
    Curr Opin Pharmacol; 2022 Apr; 63():102175. PubMed ID: 35065385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
    Rawji KS; Yong VW
    Clin Dev Immunol; 2013; 2013():948976. PubMed ID: 23840244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology.
    Walsh AD; Nguyen LT; Binder MD
    ASN Neuro; 2021; 13():1759091420981182. PubMed ID: 33517686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia: origins, homeostasis, and roles in myelin repair.
    Lloyd AF; Davies CL; Miron VE
    Curr Opin Neurobiol; 2017 Dec; 47():113-120. PubMed ID: 29073528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia regulation of central nervous system myelin health and regeneration.
    Kent SA; Miron VE
    Nat Rev Immunol; 2024 Jan; 24(1):49-63. PubMed ID: 37452201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapies to target CNS pathophysiology in multiple sclerosis.
    Oh J; Bar-Or A
    Nat Rev Neurol; 2022 Aug; 18(8):466-475. PubMed ID: 35697862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
    Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and Preparation of Cells from Focal Remyelinating Central Nervous System Lesions for RNA Sequencing.
    Davies CL; Gyoneva S; Cotleur A; Ransohoff RM; Miron VE
    Methods Mol Biol; 2019; 1936():23-36. PubMed ID: 30820891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and Molecular Mechanisms Underpinning Macrophage Activation during Remyelination.
    Lloyd AF; Miron VE
    Front Cell Dev Biol; 2016; 4():60. PubMed ID: 27446913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages.
    Sikkema AH; Stoffels JMJ; Wang P; Basedow FJ; Bulsink R; Bajramovic JJ; Baron W
    J Neuroinflammation; 2018 Aug; 15(1):218. PubMed ID: 30071854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The good, the bad and the ugly. Macrophages/microglia with a focus on myelin repair.
    Doring A; Yong VW
    Front Biosci (Schol Ed); 2011 Jun; 3(3):846-56. PubMed ID: 21622236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.